Globe Badania Kliniczne Sp. z o.o.
- Address
- Ul. Janusza Kusocinskiego 3a, 57-300 Kłodzko, Poland
Globe Badania Kliniczne - Inflammatory and Autoimmune Disease Research
Globe Badania Kliniczne Sp. z o.o. is a specialized clinical research center with extensive expertise in conducting trials for inflammatory and autoimmune conditions. The facility demonstrates particular proficiency in evaluating novel therapeutic agents and biologics across multiple disease states, focusing on moderate to severe manifestations that significantly impact patient quality of life.
- Inflammatory Bowel Disease (Crohn's Disease and Ulcerative Colitis) with emphasis on clinical remission and endoscopic response endpoints
- Dermatological conditions including moderate to severe atopic dermatitis and plaque psoriasis
- Long-term safety and maintenance therapy studies for chronic inflammatory conditions
- Biosimilar development and comparative efficacy trials
The center's research portfolio encompasses both induction and maintenance therapy trials, demonstrating capability in long-term follow-up studies that assess sustained efficacy and safety profiles. Their experience includes evaluating diverse therapeutic modalities from oral medications to subcutaneous biologics, utilizing validated outcome measures such as EASI scores for atopic dermatitis, PASI scores for psoriasis, and established clinical remission criteria for inflammatory bowel disease. This comprehensive approach positions Globe Badania Kliniczne as a valuable partner for pharmaceutical companies developing treatments for complex immune-mediated inflammatory disorders.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 3 by active trials.
lock +2 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
lock +5 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 1 624 other sites in Poland
Therapeutic Area Benchmark — Poland
Select a therapeutic area to compare against other sites in Poland.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Poland
Market Share
Country: Poland
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Globe Badania Kliniczne Sp. z o.o.
lock Showing 1 of 18 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Comparative Efficacy, Safety, and Immunogenicity of Intravenous AVT16 Versus Vedolizumab in Adults with Moderate to Severe Active Ulcerative Colitis | Alvotech Swiss AG | Phase III | Not Recruiting | Aug 2025 | Oct 2025 |
IMP list
lock Showing 1 of 12 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Duvakitug | 6 | Unknown | 2023-03-17 | 2026-07-22 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.